• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE INNOVA SELF-EXPANDING STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE INNOVA SELF-EXPANDING STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number UNK695
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vasoconstriction (2126)
Event Date 01/13/2016
Event Type  Injury  
Manufacturer Narrative
Device evaluated by mfr.: the device was not received for analysis.The batch number is unknown and the manufacturing records for the complaint device could not be reviewed.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
Same case as: mdr id: 2134265-2016-01479.(b)(6).It was reported that vessel spasm occurred.In (b)(6) 2014, the patient presented as an outpatient and was treated with antiplatelet therapy or given a dose prior to the index procedure.The target lesion was located in the left mid (superficial femoral artery (sfa) with 90% stenosis, was 50 mm long and a reference vessel diameter of 5.5 mm, and was classified as a tasc ii a lesion.The target lesion was treated with pre-dilatation and placement of a drug eluting stent (des) sfa stent.Following post-dilatation, residual stenosis was 0%.A previously implanted innova self-expanding stent was found to have 90% in-stent restenosis (isr).Percutaneous transluminal angioplasty (pta) was performed to treat the isr of the innova self-expanding stent.In (b)(6) 2016, a de novo stenosis was stented in the left proximal sfa.Subsequently, a 6 x 60 innova self-expanding stent was dilated and when the sheath was removed, a spasm of the sfa was observed and was subsequently dilated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA SELF-EXPANDING STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5489258
MDR Text Key39977353
Report Number2134265-2016-01478
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 02/10/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/09/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK695
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/10/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
-
-